GoodRx Holdings, Inc. (GDRX) stock
GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.47−0.04 (-1.14%)
Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –
GoodRx r&d expenses
Research and development expenses are spending on new products and technology.
GoodRx's R&D Expenses for the twelve months ending Jun 30, 2026 was $116.84M, down 5.0% year over year. For fiscal 2025 it was $121.03M, down 2.2% from the year before. The highest annual figure on record is $143.14M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.03M | -2.2% |
| FY2024 | Dec 31, 2024 | $123.75M | -8.9% |
| FY2023 | Dec 31, 2023 | $135.84M | -5.1% |
| FY2022 | Dec 31, 2022 | $143.14M | +13.7% |
| FY2021 | Dec 31, 2021 | $125.86M | +103.6% |
| FY2020 | Dec 31, 2020 | $61.82M | +111.0% |
| FY2019 | Dec 31, 2019 | $29.30M | -33.2% |
| FY2018 | Dec 31, 2018 | $43.89M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.71M | -10.8% |
| Q1 FY2026 | Mar 31, 2026 | $30.18M | -3.1% |
| Q4 FY2025 | Dec 31, 2025 | $28.94M | -8.8% |
| Q3 FY2025 | Sep 30, 2025 | $31.01M | +2.9% |
| Q2 FY2025 | Jun 30, 2025 | $29.93M | -3.0% |
| Q1 FY2025 | Mar 31, 2025 | $31.14M | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | $31.74M | -0.9% |
| Q3 FY2024 | Sep 30, 2024 | $30.14M | -23.9% |
| Q2 FY2024 | Jun 30, 2024 | $30.85M | -1.4% |
| Q1 FY2024 | Mar 31, 2024 | $31.02M | -5.7% |
| Q4 FY2023 | Dec 31, 2023 | $32.03M | -12.9% |
| Q3 FY2023 | Sep 30, 2023 | $39.61M | +10.3% |
| Q2 FY2023 | Jun 30, 2023 | $31.29M | -11.6% |
| Q1 FY2023 | Mar 31, 2023 | $32.91M | -6.1% |
| Q4 FY2022 | Dec 31, 2022 | $36.77M | +4.9% |
| Q3 FY2022 | Sep 30, 2022 | $35.92M | +2.4% |
| Q2 FY2022 | Jun 30, 2022 | $35.40M | +19.7% |
| Q1 FY2022 | Mar 31, 2022 | $35.04M | +34.0% |
| Q4 FY2021 | Dec 31, 2021 | $35.06M | +48.0% |
| Q3 FY2021 | Sep 30, 2021 | $35.07M | +121.3% |
| Q2 FY2021 | Jun 30, 2021 | $29.57M | +147.2% |
| Q1 FY2021 | Mar 31, 2021 | $26.16M | +153.4% |
| Q4 FY2020 | Dec 31, 2020 | $23.68M | +141.2% |
| Q3 FY2020 | Sep 30, 2020 | $15.85M | +102.0% |
| Q2 FY2020 | Jun 30, 2020 | $11.96M | – |
| Q1 FY2020 | Mar 31, 2020 | $10.33M | – |
| Q4 FY2019 | Dec 31, 2019 | $9.82M | – |
| Q3 FY2019 | Sep 30, 2019 | $7.84M | – |
See a number that looks wrong?